Insider Cluster (2 insiders) ·Filed May 18, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $5.7M total
Actionable Insight • Neutral

The selling is routine in scale and pattern relative to TEVA's $39.9B market cap. Per academic literature, insider cluster sales are not predictive of forward returns — especially when trending over multiple weeks. No action warranted. Monitor for any earnings or clinical/regulatory catalyst that could change the business outlook.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
TEVA ▲ +6.98% at T+60d
NEUTRAL call ✓ call won +6.98% · α vs SPY +0.96% · entry $34.07 → $36.45
Entry anchored
May 18, 2026
via day open
T+1d
+0.64%
call +0.64% · α -0.40%
$34.29
settled 5mo ago
T+5d
+1.04%
call +1.04% · α -1.25%
$34.43
settled 4mo ago
T+20d
-3.40%
call -3.40% · α -5.67%
$32.91
settled 4mo ago
T+60d
+6.98%
call +6.98% · α +0.96%
$36.45
settled 7w ago

Price Chart

Loading chart...

Executive Summary

TEVA insiders sold $5.66M in stock on May 14, 2026, led by CFO Eliyahu Sharon Kalif ($5.46M). The sales occurred at ~$35.60, with no open-market purchases by any insider. Relative to TEVA's $39.9B market cap, the cluster represents ~0.014% — trivial in proportional terms. Previous 30-day insider activity shows a consistent selling pattern ($12.9M over 6 sales), suggesting this is routine portfolio diversification or liquidity-driven selling, not an informed bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$5.7M
Insiders
2

Key Facts

  • CFO sold 153,251 shares for $5.46M; SVP Business Development sold 5,746 shares for $0.20M
  • Total cluster value: $5.66M, representing approximately 0.014% of TEVA's $39.9B market cap
  • No open-market purchases in the 7-day cluster window or in the prior 30 days (6 sales totaling $12.9M)
  • Non-cash derivative exercises by Lippman (11,841 shares at $0) are tax/paper events with zero economic value

Financial Impact

$5.66M in insider sales, ~0.014% of market cap. Trivial relative to TEVA's size.

insider holdings

Risk Factors

  • Persistent insider selling without purchases could erode management credibility if fundamentals deteriorate

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TEVA-1779134594069
31 reports for TEVA
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+20▲ +17.61%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%$39.29 (+8.09%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%$39.29 (+6.88%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%$39.29 (+4.80%)
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%$39.29 (+7.82%)
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%$39.29 (+8.72%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%$39.29 (+12.87%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%$39.29 (+12.23%)
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%$39.29 (+13.20%)
Showing 10 of 31

US Market Status

Market Open — Closes in 3h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 18, 2026